ReviewAmerican journal of cancer research2020
Applications of radiomics in genitourinary tumors.
Review in American journal of cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 17 citations in OpenAlex.
- Predicting inguinal lymph node metastasis in penile squamous cell carcinoma, from imaging, molecular biomarkers to multimodal AI: a narrative review.Translational andrology and urology · 2026Review
- Magnetic Resonance Imaging Radiomics-Driven Artificial Neural Network Model for Advanced Glioma Grading Assessment.Medicina (Kaunas, Lithuania) · 2025Article
- MRI-derived radiomics models for diagnosis, aggressiveness, and prognosis evaluation in prostate cancer.Journal of Zhejiang University. Science. B · 2023Review
- A machine learning approach to distinguishing between non-functioning and autonomous cortisol secreting adrenal incidentaloma on magnetic resonance imaging using texture analysis.Irish journal of medical science · 2023Article
- Radiomics and Radiogenomics in Pelvic Oncology: Current Applications and Future Directions.Current oncology (Toronto, Ont.) · 2023Review
- Radiomics vs radiologist in bladder and renal cancer. Results from a systematic review.Central European journal of urology · 2023Review
- CT imaging findings of renal epithelioid lipid-poor angiomyolipoma.European radiology · 2022Article
- A combined predicting model for benign esophageal stenosis after simultaneous integrated boost in esophageal squamous cell carcinoma patients (GASTO1072).Frontiers in oncology · 2022Article
- Article
- Studying local tumour heterogeneity on MRI and FDG-PET/CT to predict response to neoadjuvant chemoradiotherapy in rectal cancer.European radiology · 2021Article
- Radiomics in Oncology, Part 1: Technical Principles and Gastrointestinal Application in CT and MRI.Cancers · 2021Review
- Radiomics and Prostate MRI: Current Role and Future Applications.Journal of imaging · 2021Review
- Background, applications and challenges of radiogenomics in genitourinary tumor.American journal of cancer research · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Genitourinary tumors are heterogeneous groups of tumors with high morbidity and mortality rates. Confronted with existing problems in the management of genitourinary tumors, a personalized imaging method called radiomics shows great potential in areas including detection, grading, and treatment response assessment. Radiomics is characterized by extraction of quantitative imaging features which are not visible to the naked eye from conventional imaging modalities such as computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography-computed tomography (PET-CT), followed by data analysis and model building. It outperforms other invasive methods in terms of non-invasiveness, low cost and high efficiency. Recently, a number of studies have evaluated the application of radiomics in patients with genitourinary tumors with promising data. The combination of radiomics and clinical/laboratory factors provides added value in many studies. Despite this, there are limitations and challenges to be overcome before a more extensive clinical application in the future. In this article, we will introduce the concept, significance and workflow of radiomics, review their current applications in patients with genitourinary tumors and discuss limitations and future directions of radiomics. It would help multidisciplinary team involved in the treatment of patients with genitourinary tumors to achieve a better understanding of the results of radiomics study toward a personalized medicine.
Indexed as
Identifiers
32905456PMC7471369W3085357535What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.